Early diagnosis of acute kidney injury by urinary YKL-40 in critically ill patients in ICU: a pilot study
- PMID: 31894557
- DOI: 10.1007/s11255-019-02364-2
Early diagnosis of acute kidney injury by urinary YKL-40 in critically ill patients in ICU: a pilot study
Abstract
Purpose: In critically ill patients, acute kidney injury (AKI) is a devastating problem often associated with adverse outcomes. Depending on the conventional markers for diagnosis of AKI, an undesirable delay in the diagnosis and initiation of treatment has occurred. Thus, it is challenging to find a biomarker for early diagnosis of AKI. We sought to evaluate urinary YKL-40 as a biomarker for early diagnosis of AKI among critically ill patients compared with conventional markers and to assess its relation to the severity of AKI.
Methods: Thirty-six patients without AKI at the time of ICU admission who enrolled in this prospective cohort study had the following measured: serum creatinine as well as urine YKL-40 at admission and thereafter at 4 time intervals (0, 12, and 24 ± 48 h) (therefore, we studied 94 urine samples in 36 patients). Urine YKL-40 was quantified by enzyme-linked immunosorbent assay (ELISA). AKI was defined using the Kidney Disease Improving Global Outcomes (KDIGO) criteria, which include three stages (1, 2, and 3) of progressive renal dysfunction.
Results: In this study, 18 (50%) patients developed AKI within 48-72 h. Moreover, urine YKL-40 increased significantly within 12 h in patients who developed AKI (n = 18, 11.75 ± 1.94), but not in non-AKI patients (n = 18, 5.66 ± 3.42) ng/ml (P < 0.001) and, at the same time, we did not find any significant difference in the serum creatinine levels between the two groups. In addition, AKI group showed rising levels with KIDGO classes.
Conclusion: In this pilot study we found that urinary YKL-40 can be used as a valuable and noninvasive marker for early diagnosis of AKI among critically ill patients in ICU as compared to conventional markers and its level is increasing with the severity of AKI classes. However, the small sample size is important limitation. Therefore, large multicenter studies may be needed to confirm it.
Keywords: Acute kidney injury; Critical ill patients; ICU; YKL-40.
Similar articles
-
Urinary cell cycle arrest biomarkers and chitinase 3-like protein 1 (CHI3L1) to detect acute kidney injury in the critically ill: a post hoc laboratory analysis on the FINNAKI cohort.Crit Care. 2020 Apr 10;24(1):144. doi: 10.1186/s13054-020-02867-w. Crit Care. 2020. PMID: 32276601 Free PMC article.
-
Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: a prospective cohort study in adult critically ill patients.Crit Care. 2016 Feb 11;20:38. doi: 10.1186/s13054-016-1192-x. Crit Care. 2016. PMID: 26864834 Free PMC article.
-
Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.Am J Nephrol. 2019;50(1):19-28. doi: 10.1159/000500231. Epub 2019 Jun 14. Am J Nephrol. 2019. PMID: 31203271
-
Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria.BMC Nephrol. 2017 Feb 20;18(1):70. doi: 10.1186/s12882-017-0487-8. BMC Nephrol. 2017. PMID: 28219327 Free PMC article. Review.
-
Acute kidney injury in the ICU: time has come for an early biomarker kit!Acta Clin Belg. 2007;62 Suppl 2:318-21. doi: 10.1179/acb.2007.072. Acta Clin Belg. 2007. PMID: 18283991 Review.
Cited by
-
Global Proteome and Phosphoproteome Characterization of Sepsis-induced Kidney Injury.Mol Cell Proteomics. 2020 Dec;19(12):2030-2047. doi: 10.1074/mcp.RA120.002235. Epub 2020 Sep 22. Mol Cell Proteomics. 2020. PMID: 32963032 Free PMC article.
-
Omics data integration analysis identified new biological insights into chronic antibody-mediated rejection (CAMR).J Transl Med. 2025 Feb 20;23(1):209. doi: 10.1186/s12967-025-06203-0. J Transl Med. 2025. PMID: 39979925 Free PMC article.
-
YKL-40 as a biomarker in various inflammatory diseases: A review.Biochem Med (Zagreb). 2024 Feb 15;34(1):010502. doi: 10.11613/BM.2024.010502. Epub 2023 Dec 15. Biochem Med (Zagreb). 2024. PMID: 38125621 Free PMC article. Review.
-
Inflammatory Effects and Regulatory Mechanisms of Chitinase-3-like-1 in Multiple Human Body Systems: A Comprehensive Review.Int J Mol Sci. 2024 Dec 15;25(24):13437. doi: 10.3390/ijms252413437. Int J Mol Sci. 2024. PMID: 39769202 Free PMC article. Review.
-
Urinary cell cycle arrest biomarkers and chitinase 3-like protein 1 (CHI3L1) to detect acute kidney injury in the critically ill: a post hoc laboratory analysis on the FINNAKI cohort.Crit Care. 2020 Apr 10;24(1):144. doi: 10.1186/s13054-020-02867-w. Crit Care. 2020. PMID: 32276601 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources